Home > Insider Trading > Filing (0001104659-10-060757)

Filing Details

Accession Number:: 0001104659-10-060757
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-01 18:08:06
Reporting Period:: 2010-11-30

Filing Date:: 2010-12-01
Accepted Time:: 2010-12-01 18:08:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1352036	P L Fund Annex Ii Aberdare	One Embarcadero Center Suite 4000 San Francisco CA 94111	No	No	Yes	No
1418075	Aberdare Ventures Ii (Bermuda), L.p.	One Embarcadero Center Suite 4000 San Francisco CA 94111	No	No	Yes	No
1418078	Aberdare Gp Ii, L.l.c.	One Embarcadero Center Suite 4000 San Francisco CA 94111	No	No	Yes	No
1418079	Aberdare Ventures Ii, L.p.	One Embarcadero Center Suite 4000 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-30	324,975	$0.00	324,975	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-11-30	337,831	$0.00	662,806	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-11-30	593,697	$0.00	1,256,503	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-11-30	95,788	$0.00	1,352,291	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-11-30	99,645	$0.00	1,451,936	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-11-30	300,000	$5.00	1,751,936	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2010-11-30	324,975	$0.00	324,975	$0.00
Common Stock	Series B Preferred Stock	Disposition	2010-11-30	256,651	$0.00	337,831	$0.00
Common Stock	Series C Preferred Stock	Disposition	2010-11-30	593,697	$0.00	593,697	$0.00
Common Stock	Series D Preferred Stock	Disposition	2010-11-30	95,788	$0.00	95,788	$0.00
Common Stock	Series E Preferred Stock	Disposition	2010-11-30	99,645	$0.00	99,645	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Series A-1 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date.
The Series B Preferred Stock converted into Common Stock on the basis of 1.316 shares of Common Stock for one share of Series B Preferred Stock and had no expiration date.
Consists of 7,203 shares held by Aberdare Ventures II, L.P. ("Aberdare Bermuda") and 317,772 shares held be Aberdare Ventures II, L.P. ("Aberdare II"). Aberdare GP II, L.L.C. ("Aberdare GP II") serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Paul H. Klingenstein ("Klingenstein") is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.
Consists of 7,488 shares held by Aberdare Bermuda. and 330,343 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.
Consists of 13,160 shares held by Aberdare Bermuda and 580,537 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.
Consists of 2,123 shares held by Aberdare Bermuda and 93,665 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.
Consists of 99,645 shares held by Aberdare II Annex Fund, L.P. ("Aberdare Annex"). Aberdare GP II serves as the sole General Partner of Aberdare Annex, and has sole voting and investment control over the shares owned by Aberdare Annex, and may be deemed to own beneficially the shares held by Aberdare Annex. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Annex. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.
Consists of 300,000 shares held by Aberdare Annex. Aberdare GP II serves as the sole General Partner of Aberdare Annex, and has sole voting and investment control over the shares owned by Aberdare Annex, and may be deemed to own beneficially the shares held by Aberdare Annex. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Annex. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.